Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 23Neoplasm Metastasis 14Neoplasms 13Rectal Neoplasms 8Colorectal Cancer Metastatic 6Ovarian Neoplasms 5Lymphoma, Non-Hodgkin 5Colonic Neoplasms 5Uveal Melanoma 4Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Melanoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Burkitt Lymphoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Urethral Neoplasms 3Stomach Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Glioblastoma 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3

Interventions

sintilimab 1danvatirsen 1catumaxomab 1aflibercept 1Zoledronic Acid 1Quality of Life 1Portasystemic Shunt, Transjugular Intrahepatic 1Octreotide 1Nutritional Status 1Interviews as Topic 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ascites × aflibercept × Clear all
NCT00327444 2013-01-01

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Sanofi

Phase 2/3 Completed
58 enrolled 11 charts
Gynecologic

Ascites, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡